NCT05418608View on ClinicalTrials.gov

Novel in Vivo Synaptic Imaging in Experienced Meditators

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 21, 2022

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2024

Conditions
Behavior, Health
Interventions
DRUG

Radiotracer

A novel SV2A imaging tracer which is used in conjunction with positron emission tomography scans.

Trial Locations (1)

06519

Yale University PET Center, New Haven

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

Yale University

OTHER